Goldman Sachs’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-564,120
| Closed | -$2.23M | – | 6819 |
|
|
2021
Q1 | $2.23M | Sell |
564,120
-1,008,635
| -64% | -$3.26M | ﹤0.01% | 3882 |
|
|
2020
Q4 | $3.67M | Hold |
1,572,755
| – | – | ﹤0.01% | 3250 |
|
|
2020
Q3 | $3.41M | Hold |
1,572,755
| – | – | ﹤0.01% | 3191 |
|
|
2020
Q2 | $3.26M | Hold |
1,572,755
| – | – | ﹤0.01% | 3107 |
|
|
2020
Q1 | $2.11M | Buy |
1,572,755
+41,922
| +3% | +$137K | ﹤0.01% | 3261 |
|
|
2019
Q4 | $5.31M | Buy |
1,530,833
+53,511
| +4% | +$169K | ﹤0.01% | 2916 |
|
|
2019
Q3 | $4.55M | Sell |
1,477,322
-93
| -0% | -$276 | ﹤0.01% | 2925 |
|
|
2019
Q2 | $4.48M | Buy |
1,477,415
+515,138
| +54% | +$1.47M | ﹤0.01% | 2927 |
|
|
2019
Q1 | $2.56M | Buy |
962,277
+611,281
| +174% | +$1.89M | ﹤0.01% | 3454 |
|
|
2018
Q4 | $1.07M | Buy |
350,996
+322,095
| +1,114% | +$1.06M | ﹤0.01% | 3919 |
|
|
2018
Q3 | $114K | Sell |
28,901
-92,932
| -76% | -$342K | ﹤0.01% | 5092 |
|
|
2018
Q2 | $378K | Buy |
121,833
+100,432
| +469% | +$320K | ﹤0.01% | 4672 |
|
|
2018
Q1 | $55K | Buy |
+21,401
| New | +$60K | ﹤0.01% | 5454 |
|
|
2017
Q4 | – | Sell |
-54,317
| Closed | -$141K | – | 6792 |
|
|
2017
Q3 | $141K | Buy |
+54,317
| New | +$167K | ﹤0.01% | 5927 |
|
Goldman Sachs's CRHM Position: Q2 2021 in Review
Goldman Sachs sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 564,120 shares — an estimated $2.23M sold.
Goldman Sachs first reported a position in CRHM in Q3 2017 and held it in 14 quarters. The position peaked at $5.31M in Q4 2019. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.
- Goldman Sachs reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Goldman Sachs sold 564,120 CRH Medical Corporation shares in Q2 2021, an estimated $2.23M.
- Goldman Sachs first reported a position in CRH Medical Corporation in Q3 2017 and held it in 14 quarters.
- Goldman Sachs's CRH Medical Corporation position peaked at $5.31M in Q4 2019.
- 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.